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Abstract
Group B coxsackieviruses (CVB) are associated with viral-induced heart disease and are among the leading causes of aseptic
meningitis worldwide. Here we show that CVB entry into polarized brain microvasculature and aortic endothelial cells
triggers a depletion of intracellular calcium stores initiated through viral attachment to the apical attachment factor decay-
accelerating factor. Calcium release was dependent upon a signaling cascade that required the activity of the Src family of
tyrosine kinases, phospholipase C, and the inositol 1,4,5-trisphosphate receptor isoform 3. CVB-mediated calcium release
was required for the activation of calpain-2, a calcium-dependent cysteine protease, which controlled the vesicular
trafficking of internalized CVB particles. These data point to a specific role for calcium signaling in CVB entry into polarized
endothelial monolayers and highlight the unique signaling mechanisms used by these viruses to cross endothelial barriers.
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Introduction
Coxsackievirus B (CVB), a member of the enterovirus family, is
associated with a number of diverse syndromes including aseptic
meningitis, myocarditis, febrile illness, and diabetes [1]. CVBs are
transmitted via the fecal-oral route and encounter the polarized
epithelium lining the gastrointestinal tract early in infection.
Following dissemination, CVBs likely access secondary sites of
infection via transmission through an endothelial monolayer such as
that of the blood-brain barrier (BBB) and/or venous endothelium.
Thus, although both polarized epithelial and endothelial cells
function to prevent pathogen access to the interstitium, CVBs have
developed strategies to subvert these barriers in order to promote
their entry and/or dissemination. We have shown that CVB entry
into polarized intestinal epithelial cells requires the activation of
specific intracellular signaling molecules to promote viral endocy-
tosis [2,3]. However, it remains unclear if CVB also requires the
initiation of host cell signaling to facilitate its entry (a process
involving both endocytosis and vesicular trafficking) into the
endothelium and whether the same signals are required between
the epithelium and endothelium.
The binding of viruses to receptors on host cells often initiates
elaborate signaling pathways aimed at facilitating viral uptake.
The coxsackievirus and adenovirus receptor (CAR) mediates
attachment by all six CVB serotypes [4], but is inaccessible to
viruses on the luminal surface due to its localization within
intercellular tight junctions [5]. For this reason, polarized cells are
often resistant to infection by a number of CVB isolates [5]. Decay
accelerating factor (DAF) is a glycosylphosphatidylinositol (GPI)-
anchored membrane protein shown to bind several isolates of
CVB (21, 23, and 25) [4,6,7,8,9] and promote their infection of
polarized cells [5]. As DAF is a GPI-anchored protein, it is
localized to the apical surface of polarized cells and is accessible to
virus in the lumen. In addition to providing a convenient site for
virus attachment, the GPI anchor of DAF also facilitates its
association with cholesterol-enriched lipid microdomains [10].
Lipid rafts are enriched in a number of signaling molecules
including receptor tyrosine kinases, the Src family of nonreceptor
tyrosine kinases, small G proteins, and adenylyl cyclases (ACs)
[11].
Although DAF is anchored to the outer leaflet of the plasma
membrane via a GPI anchor (and thus does not contain an
intracellular domain), DAF and other GPI-anchored membrane
proteins can be induced to form larger raft patches upon lateral
crosslinking (most commonly with antibodies) [12]. We have
shown previously that CVB-induced DAF clustering is essential for
downstream signaling events required to facilitate virus entry into
polarized intestinal epithelial cells [2]. Two tyrosine kinases (Abl
and Fyn) are activated by DAF clustering and both are required
for CVB entry into polarized epithelial cells [2]. Although
clustering of GPI-anchored proteins is most commonly associated
with the initiation of tyrosine kinase-based signaling cascades, the
release of intracellular calcium (Cai
2+) following lateral cross-
linking of these receptors has also been documented [13].
Antibody-mediated crosslinking of DAF has been linked to the
release of Cai
2+ [14,15] as a means to initiate monocyte activation
[16].
Calcium is one of the most prominent second messengers in the
cell. It is involved in many signaling cascades that have diverse
outcomes depending on the spatiotemporal aspects of the calcium
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release. For this reason, intracellular calcium (Cai
2+) homeostasis is
under tight regulation by the cell. The free cytoplasmic calcium
concentration is maintained around 50–100 nM whereas intra-
cellular stores such as the ER (endoplasmic reticulum) maintain
much higher free concentrations (mM amounts). Intracellular
calcium levels rise upon a stimulus (such as ligand-receptor
interaction on the cell surface) and often converge on phospho-
lipase C (PLC), an enzyme that mediates the hydrolysis of
phosphatidylinositol-4,5-bisphophate (PIP2) into diacylglycerol
(DAG) and inositol 1,4,5-trisphosphate (IP3). IP3 diffuses through
the cytoplasm and binds to IP3 receptors (IP3R) localized on the
ER membrane. Cytoplasmic calcium levels are brought back
down to basal concentrations by multiple calcium channels such as
the plasma membrane Ca2+-ATPase (PMCA), as well as the sarco-
endoplasmic reticulum ATPase (SERCA) pump. As Cai
2+ levels
regulate a variety of cellular processes, it is not surprising that
many viral pathogens have evolved strategies to exploit Ca2+-
mediated signaling events to promote mechanisms required to
facilitate viral entry, replication, and/or spread [17].
Our previous studies have highlighted the intracellular signals
that regulate CVB entry into polarized epithelial cells [2,18]. In
the present study, we have defined the role of Cai
2+ in facilitating
CVB entry into human brain microvascular endothelia cells
(HBMEC), an in vitro model of the blood-brain barrier. These
studies have revealed that CVB-induced clustering of DAF
induces an immediate depletion of Cai
2+ stores. CVB-induced
Cai
2+ mobilization is regulated by several host cell factors
including the Src family of tyrosine kinases, PLC, and is mediated
specifically by the IP3R isoform 3. We also show that the calpain
family of Ca2+-activated proteases plays a role in mediating the
trafficking of CVB-containing vesicles within the cell. Interest-
ingly, we also find that Cai
2+ release is involved in mediating
CVB entry into primary human aortic endothelial cells, but is not
required for CVB entry into polarized epithelial cells, suggesting
that the intracellular signaling molecules hijacked by CVB to
facilitate entry are distinct between the endothelium and
epithelium.
Results
The mechanism of CVB entry is distinct between the
endothelium and epithelium
Nonenveloped viruses gain entry into host cells by endocytic
mechanisms that may include clathrin- or caveolar-mediated
endocytosis, and macropinocytosis [19]. Some of these pathways
are dependent upon the activity of dynamin, a GTPase required
for vesicle fission. In previous studies, we found that CVB entry
into polarized intestinal epithelial Caco-2 cells was independent of
dynamin II [2] and occurred by a pathway that incorporates
aspects of both caveolar-mediated endocytosis and macropinocy-
tosis [3]. Because of the unique aspects of this pathway, we
determined whether CVB entry into HBMEC occurrs via a similar
mechanism. [Unless otherwise stated, all experiments were
performed with CVB3-RD, a DAF-binding isolate of CVB].
First, we used three independent methods to alter dynamin II
activity –(1) dynasore, a cell-permeable inhibitor of dynamin [20],
(2) a dominant-negative mutant of dynamin II (dynamin II K44A)
[21], and (3) siRNA-mediated depletion of dynamin II (Supple-
mental Figure S5)–and determined the effects of this alteration on
CVB infection of HBMEC and Caco-2 cells. Under all of these
conditions, CVB infection of Caco-2 cells was unaffected
(Figure 1A) while all methods significantly reduced infection of
HBMEC by CVB (Figure 1A). Moreover, using a fluorescence-
based assay for viral internalization that discriminates between
virus on the cell surface and that which has internalized [18], we
confirmed that dynasore specifically inhibited CVB entry into
HBMEC (Figure 1B, top) while having no effect on its entry into
Caco-2 cells (Figure 1B, bottom). Interestingly, CVB infection of
primary human aortic endothelial cells (HAEC) was also inhibited
by dynasore treatment (Figure 1A), suggesting that the route of
entry of CVB into the aortic endothelium may be similar to that in
the CNS microvasculature.
We next determined the effect of dominant-negative mutants of
various endocytic pathways for their effects on CVB infection of
HBMEC. These studies revealed that CVB infection of HBMEC
was significantly impaired when mutants of the caveolar pathway
were expressed (caveolin-1 and -3), consistent with what we
observed previously in Caco-2 cells [2] (Figure 1C). Furthermore,
immunofluorescence microscopy revealed colocalization of cyto-
plasmic CVB-containing vesicles with caveolin-1 and cholera toxin
B (a marker of the caveolar pathway) (Figure 1D). In contrast,
infection was unaffected by expression of a mutant of the clathrin
endocytic pathway (Eps15) in HBMEC (Figure 1C). These data
indicate that the mechanism of CVB entry into the endothelium is
clathrin-independent, and likely occurs via a dynamin- and
caveolar-dependent pathway. In contrast, entry into the epithe-
lium occurs via a clathrin-and dynamin-independent, but
caveolin-dependent pathway [2]. Taken together, these findings
point to a divergent mechanism of endocytosis between the
endothelium and epithelium.
Ca2+ is required for CVB infection of HBMEC
We have shown that CVB entry into polarized epithelial Caco-2
cells requires the activation of intracellular signaling molecules to
facilitate viral endocytosis [2] and are initiated by viral attachment
to DAF on the apical cell surface. Because our current findings
indicate that CVB entry occurs via disparate mechanisms between
HBMEC and Caco-2 cells (Figure 1A, 1B), we investigated the
host cell signaling molecules involved in facilitating CVB entry
into HBMEC and whether these molecules were unique between
these cell types.
Author Summary
Enteroviruses are associated with a number of diverse
syndromes such as myocarditis, febrile illness, and are the
main causative agents of aseptic meningitis. No effective
therapeutics exist to combat non-poliovirus enterovirus
infections. A better understanding of the mechanisms by
which these viruses infect host cells could lead to the
design of effective therapeutic interventions. In this study,
we found that intracellular calcium stores in polarized
endothelial monolayers are depleted upon exposure to
coxsackievirus B (CVB) and that this release is mediated by
viral attachment to its receptor decay-accelerating factor.
We also discovered that the calcium release requires the
activation of signaling molecules involved in calcium
signaling such as Src tyrosine kinases, phospholipase C,
and the inositol 1,4,5-trisphosphate receptor isoform 3 on
the ER membrane. Furthermore, we found that a calcium-
activated cystein protease, calpain-2, was activated and
necessary for proper viral trafficking inside the cell.
Interestingly, we found that this signaling cascade was
critical for CVB internalization into the endothelium, but
was not involved in CVB entry into the epithelium. This is
an important advance in our understanding of how
enteroviruses hijack host endothelial cell signaling me-
chanisms in order to facilitate their entry and eventual
spread.
Calcium Facilitates Coxsackievirus Entry
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As DAF signaling has been associated with the release of
Cai
2+[14,15], we determined whether CVB infection of HBMEC
was sensitive to manipulation of Cai
2+ stores. We found that in cells
pretreated with Bapta-AM (a chelator of intracellular calcium),
infection was significantly reduced compared to no inhibitor controls
(Figure 2A). Interestingly, Bapta-AM lost its inhibitory effect when
added at a post-entry time point [2 hrs post infection (p.i.), Figure 2A],
indicating that Ca2+ may be required for events occurring at or very
close to the time of virus entry. Similar results were obtained in
primary human aortic endothelial cells (HAEC) (Figure 2A). We
found that this effect was specific for CVB as Bapta-AM had no effect
on vesicular stomatitis virus (VSV) infection of HBMEC (Supple-
mental Figure S1A). In addition, Bapta-AM had no effect on CVB
infection of intestinal epithelial Caco-2 cells either pre- or post-
treatment (Figure 2A), indicating that the role of Ca2+ in early events
associated with CVB is specific to polarized endothelia.
CVB entry induces the rapid release of Cai
2+ in HBMEC
Because we observed that Ca2+ chelation inhibited CVB infection
(Figure 2A) of HBMEC, we next determined the kinetics of CVB-
Figure 1. The CVB entry mechanism is distinct between polarized endothelia and epithelia. (A) Dynasore (100 mM), dynaminK44A, and
dynamin II siRNA all significantly inhibit CVB infection in HBMEC and HAEC, but have no effect on CVB infection in Caco-2 cells. Data are normalized to
DMSO control, wild-type dynamin II, or control siRNA-infected cells. (B) Immunofluorescence-based assay for viral internalization in HBMEC and Caco-
2 cells pre-treated with DMSO (control) or dynasore and exposed to CVB (MOI = 50) for 1 hr at 37uC. Red fluorescence (or overlapping red and green
fluorescence) indicates virus on the cell surface; green fluorescence in the absence of red indicates internalized virus. (C) HBMEC monolayers
expressing dominant-negative or wild-type forms of caveolin-1, caveolin-3, or Eps15 were exposed to CVB (MOI = 1) and stained for VP1 at 14 hr p.i.
The graph shows the number of transfected cells expressing VP1 as a percent of control infections (dashed line). (D) HBMEC monolayers exposed to
CVB (MOI = 50) and Alexa-Fluor cholera toxin-B (CTB – red) were stained for caveolin-1 (blue) and VP1 (green) at 60 min p.i.
doi:10.1371/journal.ppat.1001135.g001
Calcium Facilitates Coxsackievirus Entry
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mediated Cai
2+ release in real-time. To do this, we used live-cell
imaging of HBMEC loaded with the ratiometric Cai
2+ indicator
Fura-2 AM. This allowed for the tracking of individual cells to
pinpoint the precise timeframe during which intracellular Ca2+ store
depletion occurred. Images were captured every 5 sec at both
excitation wavelengths for Fura (340/380 nm, emission 510).
Following a brief period to establish baseline levels of Cai
2+ (t = 50
sec), CVB (MOI=50) was added directly to monolayers. To prevent
Ca2+ influx due to alterations in membrane permeability, monolayers
were bathed in Ca2+-free HEPES-buffered saline. The addition of
CVB resulted in an almost immediate release (,20sec) of Cai
2+
[shown in still images spanning 1 min from virus addition (Figure 2B,
Supplemental Movie S1)]. As quickly as 15 sec following the addition
of CVB, the majority of cells have been almost completely depleted of
Cai
2+ [shown in the graphical representation (Figure 2C)]. Of
particular significance, this depletion occurred at a time point prior to
viral uncoating (Supplemental Figure S1D) and the production of
viral proteins (Supplemental Figure S1B, S1C), which have previously
been shown to induce Cai
2+ release at late stages of virus replication
[22].
We next tested whether primary human aortic endothelial
cells (HAEC) were also depleted of Cai
2+ in response to CVB
exposure. In some cases, microvasculature and arterial en-
dothelial cells differ in the degree of tight junction function and
in their responsiveness to calcium ionophores [23]. Further-
more, myocarditis and dilated cardiomyopathy are often
associated with CVB infection and CVB may infect aortic
endothelial cells during cardiac infections [24,25]. Interestingly,
we observed the depletion of Cai
2+ in response to CVB exposure
of HAEC similar to that observed in HBMEC (Figure 2B, C).
However, CVB-induced depletion of Cai
2+ proceeded at a more
gradual pace (,120 sec) in HAEC compared to HBMEC
(Supplemental Movie S2).
Consistent with our findings that Bapta-AM had no effect on
CVB infection Caco-2 cells (Figure 1A), we found that CVB entry
had no effect on Cai
2+ levels in these cells (Figure 2B, 2C,
Supplemental Movie S3). These data indicate that the role of
Cai
2+ in mediating CVB entry is specific to the endothelium and
suggest that there may be unique signaling molecules activated
between the endothelium and epithelium.
Figure 2. Intracellular Ca2+ is required and mobilized in endothelia but not epithelia. (A) HBMEC, primary HAEC, or Caco-2 cells were
treated with Bapta-AM [in low calcium (,300 mM Ca2+)-containing media] and infected with CVB (5 PFU/cell) for 14 hrs. Inhibitor was added to
cultures 1 hour prior to infection (pre-treat) or 2 hours p.i. (post-treat). The graph indicates the percentage of cells expressing VP1 compared to no
inhibitor controls (dashed line). (B) HBMEC (left), HAEC (middle), and Caco-2 (right) monolayers were loaded with Fura-2 AM and fluorescent images
(excitation 340 and 380 nm) were taken every 5 seconds prior to and following the addition of CVB at MOI = 50 (at t = 55 seconds). Shown are images
(pseudocolored) captured at the indicated times. (C) Fluorescence intensity ratio (340/380 nm) of Fura-2-AM versus time of HBMEC (red), HAEC
(black), and Caco-2 cells (green) exposed to CVB3.
doi:10.1371/journal.ppat.1001135.g002
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DAF mediates CVB-induced Cai
2+ release
Although DAF is known to mediate CVB attachment to and
infection of polarized epithelial cells [5], little is known regarding
its role in mediating infection of the polarized endothelium.
Consistent with what has been observed in polarized intestinal
monolayers [5], we found that a non-DAF binding CVB isolate
(CVB-Nancy) was incapable of infecting HBMEC from the apical
surface (Figure 3A) and DAF siRNA (Supplemental Figure S5)
inhibited binding and infection by CVB (Supplemental Figure
S2A). This would indicate that DAF plays an essential role in
facilitating CVB infection of the endothelium [likely because CAR
is also sequestered in the tight junctions of HBMEC (Supplemental
Figure S2B) and is not exposed to virus approaching from the
apical domain].
To determine whether CVB-DAF interactions are involved in
Cai
2+ store depletion in HBMEC, we used a non-DAF binding
isolate of CVB (CVB4) and determined its effects on Cai
2+ release.
We found that CVB4 did not induce any noticeable Cai
2+ release
(Figure 3B,C) as CVB4-exposed cells retained their Cai
2+levels
throughout the entire 10 min time course (Supplemental Movie
S4).
To exclude any CAR-dependent signaling events upstream of
CVB-induced Cai
2+ release, we determined the extent of Cai
2+
release in HBMEC transfected with CAR siRNA and exposed to
DAF-binding CVB. We found that CAR siRNA (which led to a
.90% depletion of CAR expression, Supplemental Figure S5) had
no effect on CVB-induced Cai
2+ release in HBMEC (Figure 3B,
3C, and Movie S5). These data support a role for DAF, but not
CAR, in the induction of Cai
2+ release in response to CVB entry.
IP3R type 3 and PLCc are required for calcium
mobilization in response to CVB
Cai
2+ mobilization is often initiated by ligand interaction with
cell surface receptors which can lead to the activation of
intracellular signaling molecules such as tyrosine kinases, and/or
PLCs (reviewed in [26]). These molecules can either act directly to
increase IP3 levels (i.e. PLCs) or increase IP3R sensitivity to IP3
binding in the absence of the generation of new IP3 (i.e. tyrosine
kinases) [27,28,29]. To determine whether CVB-induced Cai
2+
release required the activation of PLC (and the subsequent IP3R-
mediated release of Cai
2+), we tested the effects of 2-APB (an
inhibitor of IP3R channels) and U73122 (a specific PLC inhibitor)
for their effects on CVB infection in HBMEC. We found that pre-
treatment of cells with both 2-APB and U73122 led to a significant
reduction in CVB infection (Figure 4A). In contrast, exposure of
cells to both inhibitors at a post-entry time point (2 hrs p.i.) had no
effect. We also found that U73122 inhibited Cai
2+ release in
response to CVB entry (Figure 4B). Consistent with our findings
that CVB entry into Caco-2 does not require Cai
2+ (Figure 1B), we
found that 2-APB and U73122 had no effect on CVB infection in
Caco-2 cells at either pre- or post-entry time points (Figure 4A).
Although we observed an inhibition of Cai
2+release in cells
treated with U73122, this inhibitor targets a wide range of PLC
isoforms. For this reason, we determined whether PLCc1
(PLCG1), a known mediator of Cai
2+ release, was specifically
involved in CVB-induced Cai
2+ release using siRNA-mediated
knockdown. We found that depletion of PLCc1 significantly
inhibited CVB-mediated release of Cai
2+ (Figure 4, Supplemental
Figure S5, Movie S6).
The majority of Cai
2+ oscillations within cells occur via bursts,
sparks, or waves produced by the activation of IP3R. Three IP3R
have been identified in mammalian cells that differ in their affinity
for IP3, but whose specific functions remain uncertain (reviewed
in[26]). The expression pattern of the different IP3R subtypes
between tissues is likely responsible for the variety of patterns
associated with Cai
2+ release between cell types (and may
ultimately determine the physiological outcomes of this release).
Endothelial cells generally express all three IP3R isoforms to some
degree [30–31]. We employed the use of siRNAs to specifically
knockdown IP3R isoforms expressed in HBMEC– IP3R-1, IP3R-2,
and IP3R-3 (Supplemental Figure S5). Whereas knockdown of
IP3R-1 and IP3R-2 had modest effects on CVB-induced Cai
2+
release (Supplemental Figure S3 and Movies S7 and S8),
knockdown of IP3R-3 resulted in a complete inhibition of Cai
2+
release upon exposure to CVB (Figure 4C, supplemental Movie
S9). These data indicate that while IP3R-1 and IP3R-2 may play
minor roles in mediating CVB-induced Cai
2+ release, IP3R-3 is
likely the critical IP3R isoform involved.
Src family kinases are upstream of CVB-induced Cai
2+
release
We have shown that CVB exploits DAF-mediated tyrosine
signaling pathways to surmount the epithelial barrier in order to
gain entry into polarized epithelial cells [2]. Because we observed
that CVB-induced Cai
2+ release in HBMEC required DAF-
binding (Figure 3B), we tested whether tyrosine kinases might play
a role upstream of Cai
2+ release in HBMEC. We found that
tyrosine kinase activity was required for CVB infection of
HBMEC as treatment of cells with the non-specific tyrosine
kinase inhibitor genistein reduced both CVB infection (Figure 5A)
and entry (Figure 5B). Because genistein targets a broad range of
tyrosine kinases, we determined the effects of PP2 (a specific Src
tyrosine kinase inhibitor) on CVB entry and infection. We found
that PP2 significantly reduced CVB infection (Figure 5A) and
entry (Figure 5A), indicating that Src family kinase activity is
required for CVB entry into HBMEC (similar to our previous
findings in Caco-2 cells).
Because tyrosine kinases, including members of the Src kinase
family [28,32], have been shown to function upstream of Cai
2+
release, we next determined whether tyrosine kinases and/or Src
kinase activity was required to facilitate CVB-mediated Cai
2+
release. To do this, we pre-treated HBMEC with either genistein
or PP2 and measured CVB-induced Cai
2+ release in real-time. We
found that there was a profound inhibition of CVB-induced Cai
2+
release by both genistein and PP2 compared to controls (Figure 5C
and D). We also found that genistein inhibited CVB-induced Cai
2+
release in HAEC, indicating a similar mechanism of release may
exist between the microvasculature and arterial endothelium
(Supplemental Figure S4). These data point to a role for Src family
tyrosine kinase signaling in CVB-induced Cai
2+ release.
Calpain activity is required for CVB trafficking
We recently performed an RNAi screen for host factors
involved in CVB infection of HBMEC and identified calpain-2,
a Cai
2+-dependent cysteine protease, as being required for CVB
infection of HBMEC (CB Coyne and S Cherry, unpublished data).
Members of the calpain family are activated by release of Cai
2+
and can be categorized into two subfamilies–m-calpains (eg.,
calpain-1) are activated by micromolar concentrations of Cai
2+;
and m-calpains (eg., calpain-2) are activated by millimolar
concentrations of Cai
2+ [reviewed in [33]]. We found that whereas
siRNA-mediated knockdown of calpain-2 decreased CVB infec-
tion significantly, downregulation of calpain-1 had little effect
(Figure 6A, bottom, and Supplemental Figure S5). In accordance
with our findings that Cai
2+ plays no role in CVB entry into Caco-
2 cells (Figure 2A, 2B, 4A), we found that reduction of calpain-2
expression had no effect on CVB infection of Caco-2 cells
(Figure 6A, bottom).
Calcium Facilitates Coxsackievirus Entry
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Figure 3. DAF mediates CVB-induced Cai
2+ release. (A) HBMEC grown in transwells were exposed to CVB3-RD or CVB3-Nancy (a non-DAF
binding isolate) on the apical and basolateral side, infected for 14 hrs, and fixed and stained for the VP1. Shown are the percentage of infected cells
(normalized to DAPI-stained nuclei). (B) HBMEC monolayers loaded with Fura-2 AM were exposed to CVB4, a non-DAF binding CVB isolate, at t = 55
seconds with MOI = 100 (left). HBMEC monolayers transfected with CAR (middle) or control (right) siRNAs were loaded with Fura-2AM and exposed to
Calcium Facilitates Coxsackievirus Entry
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To confirm the role of calpain-2 in mediating CVB infection of
HBMEC, we treated cells with three known inhibitors of calpains–
ALLN, calpeptin, and calpain inhibitor III—and found that they
significantly reduced infection by CVB in HBMEC (Figure 6B).
Likewise, HAEC pre-treated with calpain inhibitor III also had a
significant reduction in infection (Supplemental Figure 6B). In
contrast, calpain activity was not required for CVB infection in
Caco-2 cells (Supplemental Figure S6A). Although inhibition of
calpain activity exhibited potent reduction in CVB infection when
cells were pretreated with inhibitor, we found that this effect did
not occur when calpain inhibitors were added at post-entry time
points (2 hr p.i.) (Figure 6B and Supplemental Figure S6B). These
findings suggest that calpain activity is required early in the life
cycle of CVB (possibly at or near the time of viral entry).
Consistent with this, we found that calpains were activated by 30
min p.i., (Figure 6C), likely coincident with CVB entry and
following the release of Cai
2+ induced by CVB binding.
To further define the mechanism by which calpain-2 facilitates
CVB infection we used a fluorescence-based assay for viral
internalization. Using this assay, we found that while calpain
activity was not required for viral endocytosis into the cytoplasm, it
was required for proper vesicular trafficking as we observed the
appearance of large CVB-containing intracellular vesicles
.500 nm in diameter (much larger than the average size of
endosomes) when calpain activity was inhibited in HBMEC
(Figure 6D and Supplemental Figure S6C,D). These large
structures remained in the cytoplasm for extended periods of time
(.5 hours, not shown) whereas in untreated cells these vesicles
traveled to a perinuclear compartment by 60–120 min (where the
release of viral RNA likely occurs). In contrast, inhibition of
calpain activity had no effect on CVB entry or trafficking within
Caco-2 cells (Figure 6D). We found that these long-lived
cytoplasmic virus-containing vesicles were heavily associated with
calpain-2 (Figure 6E) and cholera toxin B (Figure 6F). However,
we did not observe any significant colocalization between
internalized CVB particles and calpain-2 in control cells
(Figure 6E). Although calpain-2 has been shown to regulate
endosomal trafficking [34,35], it remains unclear if calpain
associates with endosomal membranes for any significant length
of time. Consistent with a potential transient interaction between
calpain-2 and endosomal membrane protein components, we also
did not observe any significant colocalization between calpain-2
and a component of early endosomes (Rab5 GTPase) (Supple-
mental Figure S6F). Taken together, these data suggest that Cai
2+
release results in the specific activation of calpain-2 that in turn
facilitates the trafficking of virus-containing vesicles within the
cytoplasm to a perinuclear location for uncoating and RNA
replication to ensue. Furthermore, the role of calpain-2 is specific
to the endothelium as inhibition of calpain activity had no effect
on CVB infection of intestinal epithelial cells.
Because both PLCc1 and IP3R-3 appeared to play significant
roles in mediating Cai
2+ signaling in response to CVB entry, we
next determined whether they were also involved in facilitating
CVB entry and/or trafficking. Similar to our findings when
calpain activity was inhibited, we found that knockdown of PLCc1
and IP3R-3 also altered the ability of internalized CVB particles to
properly traffic within the cytoplasm and led to the accumulation
of long-lived CVB-containing vesicles within the cytoplasm
(Figure 6G and Supplemental Figure 6E). These data suggest that
the PLCc1- and IP3R-3-dependent Cai
2+ release induced by CVB
entry is required for the activation of calpain-2 to facilitate
vesicular trafficking of internalized viral particles.
Discussion
Many viral pathogens have developed strategies to subvert the
barriers presented by epithelia and endothelia in order to infect
the host or spread to secondary sites of infection. The CNS and
heart are common sites of CVB secondary infection. In order to
infect these tissues, circulating CVB would require passage
through or infection of the endothelium in order to traffic from
the circulatory system into the underlying tissue (through a
process that likely requires apical DAF engagement). Our
previous studies have established that CVB enters polarized
cells by endocytic mechanisms that require activation of specific
intracellular signaling molecules including the tyrosine kinases
Fyn and Abl [2,18]. Here we show how CVB specifically exploits
Cai
2+-mediated signaling events in order to facilitate its entry
into polarized endothelial cells. We provide evidence that CVB-
induced Cai
2+ release is triggered by virus binding to DAF and
involves the activity of the Src family of tyrosine kinases, PLCc1,
and the expression of a specific IP3R isoform, IP3R-3. The
release of Cai
2+ induced by CVB is required for the subsequent
activation of calpain-2, which facilitates CVB vesicular traffick-
ing. We also show that the Cai
2+-dependence of CVB entry is
specific to the endothelium and is not involved in mediating
CVB entry into the epithelium. The necessity for Cai
2+ release in
endothelia, but not epithelia, demonstrates that the entry of
CVB (and likely other viral pathogens) is mediated by cell-type-
specific intracellular signals that may differ between polarized
cell types.
Viral receptors often facilitate host cell signaling events required
for virus entry. Our results show that CVB-induced Cai
2+ release is
triggered by CVB-DAF interactions and occurs even in the
absence of CAR expression (Figure 3B). This is not surprising
given that DAF is located within lipid raft domains [2] and is in
close proximity to signaling molecules such as receptor tyrosine
kinases and PLCs [11]. CD59, another GPI-anchored receptor,
leads to the recruitment of tyrosine kinases, the heterotrimeric G
protein Gai2, and PLCc1 upon antibody-induced lateral cross-
linking. This crosslinking leads to the activation of PLCc1 and a
subsequent burst in Cai
2+ [13]. It is therefore likely that CVB
exploits Cai
2+-associated signaling events associated with DAF
crosslinking in order to facilitate its entry and intracellular
trafficking.
Several viruses have been shown to manipulate host cell Cai
2+
homeostasis in order to promote their entry and/or replication
[22,27,36,37,38,39,40,41]. Herpes simplex virus (HSV) has been
shown to utilize a transient increase in intracellular Cai
2+
concentration triggered by receptor binding to promote its
internalization [42]. Similar to our findings with CVB, HSV-
induced Cai
2+ release is mediated by the activation of PLC and
subsequent activation of IP3R [43]. In addition, depletion of ER-
derived Ca2+ stores inhibits infection of SV40, suggesting that
there may be modulation of Cai
2+ homeostasis induced during its
entry [44]. It is thus becoming clear that viruses from several
unrelated families have developed strategies to target Cai
2+
signaling in order to facilitate their entry.
CVB3-RD (MOI = 100, t = 55 seconds). Shown are images (pseudocolored) captured at the indicated times. (C) Fluorescence intensity ratio of (340/
380 nm) of Fura-2AM versus time of HBMEC monolayers exposed to CVB4 (red) or control- (green) or CAR-transfected (black) siRNAs exposed to
CVB3.
doi:10.1371/journal.ppat.1001135.g003
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Tyrosine kinase signaling often functions upstream of Cai
2+
release to activate PLCc and/or directly phosphorylate IP3Rs.
The role for Src family tyrosine kinases in the release of Cai
2+ is
clear–mice deficient in Fyn kinase are devoid of certain types of
Cai
2+ release [45], c-Src-specific antibodies inhibit PLCc-depen-
dent Cai
2+ release [46,47], and Fyn directly phosphorylates IP3R
to permit extended Cai
2+ release upon IP3 binding [32] [28]. We
found that Src kinases were critical for CVB-induced Cai
2+ release.
Interestingly, our previous work has shown that Src kinases,
specifically Fyn, mediate the entry of CVB into intestinal Caco-2
cells [2]. However, here we show that Cai
2+ plays no role in CVB
entry into Caco-2 cells, indicating that although Src kinases
facilitate CVB entry into both polarized epithelia and endothelia,
they target divergent downstream targets to do so. We also show
that inhibition of Src kinase activity prevents CVB entry into
HBMEC (Figure 5B). However, the point in the entry process that
was inhibited by Src kinase inhibition (e.g. cell surface) was unique
from what we observed by inhibiting calpains or PLCc and IP3R-3
expression (e.g. intracellular viral trafficking). As Src kinases
function in many aspects of endocytosis [48–49], these data
indicate that they likely serve multiple functions in regulating CVB
entry into HBMEC beyond that of Cai
2+ release. Taken together,
our findings indicate that Src kinases are pivotal regulators of
CVB-induced signal propagation in the endothelium and
epithelium, but likely target unique downstream effector molecules
to facilitate CVB entry.
Src kinases have been shown to directly phosphorylate IP3Rs in
order to modulate their affinity for IP3s and/or alter their gating
kinetics [32] [28]. There are three isoforms of the IP3R in
mammalian cells, but the precise function and cellular requirement
for each isoform remains uncertain. Although functional redundancy
likely exists between isoforms, IP3R-specific localization, gating, and
regulation by ligands/proteins for specific cell processes contributes to
isoform-specific signaling. Our results indicate that Cai
2+ release
downstream of CVB-induced DAF clustering is mediated via
activation of IP3R-3, as siRNA targeting IP3R-3 inhibited this release
(Figure 4C). However, other Ca2+ channels may be involved as we
cannot exclude the possibility that channels (such as store-operated
cation channels or Ca2+-release activated channels) are activated via
IP3R-3-mediated Ca
2+ release to induce Ca2+ influx. Interestingly,
caveolin-1 has been shown to directly bind IP3R-3 to regulate
agonist-induced Cai
2+ release [50] and the endothelium of mice
deficient in caveolin-1 display alterations in Cai
2+ fluxes (despite
equivalent levels of IP3 production) [51]. As we found that CVB gains
entry into HBMEC via a caveolar-dependent mechanism (Figure 1),
it is conceivable that the activation of caveolar-mediated endocytosis
induced by CVB entry alters the association between caveolin-1 and
IP3R-3 to alter its gating properties and/or sensitivity to IP3 as a
mechanism to promote Cai
2+ release.
We observed pronounced activation of calpain coincident with
CVB entry (Figure 6) and calpain activity was required to regulate
the trafficking of CVB-containing vesicles within the cell
cytoplasm. Calpains are Ca2+-dependent cysteine proteases, most
of which are ubiquitously expressed, and function in many cellular
processes, although the vast majority of these functions are still
largely unclear (reviewed in [33]). Calpain substrates can include
cytoskeletal proteins, kinases and phosphatases, membrane-
associated proteins including ion channels, and various transcrip-
tion factors [33]. Several studies have linked calpains as important
regulators of viral replication. Latently infected HIV-1 cells utilize
Ca2+-dependent calpain activation in order to initiate viral
replication [52], hepatitis C virus utilizes calpain activity in the
cleavage of viral nonstructural proteins [53], and echovirus 1
requires calpains for an as-yet-unidentified facet of its replication
[54]. In contrast to these other viruses, we find that calpain-2 is
required at the time of CVB entry and has little role in post-entry
events in the virus life cycle. The precise role for calpain-2 in
regulating the trafficking of CVB-containing vesicles is uncertain.
However, calpains have been implicated in endocytosis, particu-
larly in the regulation of intracellular membrane fusion, and are
associated with coated vesicles within the cytoplasm [34,35,55]. A
role for calpain-2 in regulating vesicular fusion during CVB entry
is supported by our observation that internalized CVB particles
accumulate within enlarged cytoplasmic vesicles when calpain
activity is inhibited. Additionally, calpains have also been
associated with the remodeling of the actin cytoskeleton by
targeting a variety of actin-associated components. Thus, calpains
may facilitate CVB trafficking by modulating the actin cytoskeletal
network for proper vesicular trafficking. Calpain-2 is activated by
high levels of Cai
2+ (mM), consistent with the pronounced release
of Cai
2+ induced during CVB entry. Moreover, we also observed
the appearance of enlarged CVB-positive cytoplasmic vesicles
when the expression of PLCc1 and IP3R-3 were depleted,
supporting a role for PLCc1- and IP3R3-dependent Cai
2+ release
upstream of calpain-2 activation.
Although many viral pathogens target polarized cells, little is
known regarding the mechanisms used by viruses to enter
polarized monolayers or whether these mechanisms might differ
between the epithelium and endothelium. CVB entry into
polarized epithelial cells is a complex process that involves the
activation of a variety of intracellular signaling molecules that
regulate distinct aspects of the viral internalization process [2,3].
The results presented here show that CVB entry into polarized
endothelial cells is regulated by a divergent intracellular signaling
pathway than that in the epithelium–the mobilization of Cai
2+.
Thus, CVB has evolved to hijack two distinct pathways in the
endothelium and epithelium to bypass polarized cell barriers.
These results provide an illustration of the complexities likely to be
associated with viral internalization into polarized cells and may
serve as a model for how other viral pathogens circumvent the
barriers presented by polarized cell monolayers.
Materials and Methods
Cell culture and viruses
HBMEC were cultured in RPMI 1640 (Hyclone, Logan, Utah)
with 10% FBS (Gibco, Grand Island, New York), 10% NuSerum
(BD Biosciences, Bedford, MA), 100 U/ml of NEAA (nonessential
amino acids), MEM vitamins, and sodium pyruvate (all Hyclone),
10 U/ml of PenStrep (Gibco), and 30 mg/ml of Endothelial Cell
Figure 4. PLCc and IP3R-3 are involved in CVB-induced depletion of Cai
2+ stores. (A) HBMEC (left) or Caco-2 (right) cells treated with 2-APB
or U73122 1 hour prior to infection (pre-treat) or 2 hours p.i. (post-treat) were infected with CVB (MOI = 1) for 14 hrs (HBMEC) or 7 hrs (Caco-2). Graph
represents percentage of total cells expressing VP1 normalized to no-inhibitor controls (dashed line). (B) Top: Still images of HBMEC pre-treated with
U73122, loaded with Fura-2 AM, and exposed to CVB (MOI = 50, t = 55 seconds). Images were pseudo colored for Cai
2+ visualization. Bottom:
Fluorescence intensity ratio (340/380 nm) of Fura-2AM versus time in HBMEC exposed to CVB in the absence (black) or presence of U73122 (blue). (C)
Top: Still images captured at the indicated times in HBMEC transfected with control, IP3R-3, or PLCc-1 siRNAs, loaded with Fura-2AM and exposed to
CVB (MOI = 50, t = 55 seconds). Bottom: Intensity ratio plot (340/380 nm) of HBMEC loaded with Fura-2AM and transfected with control, IP3R-3, or
PLCc -1 siRNA and exposed to CVB (MOI = 50, t = 55 seconds).
doi:10.1371/journal.ppat.1001135.g004
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Figure 5. Src Family Tyrosine kinases are upstream of intracellular Ca2+ release in response to CVB3. (A) HBMEC (left) or HAEC (right)
monolayers were pre-treated with genistein or PP2 1 hr before (pre-treat) exposure to CVB3 or 2 hrs p.i. and infected for 14 hrs (HBMEC) or 7 hrs
(Caco-2). Shown are the percentage of infected cells (normalized to DAPI-stained nuclei) normalized to no inhibitor controls. (B)
Immunofluorescence-based assay for viral internalization in HBMEC pre-treated with no inhibitor, genistein, or PP2 and exposed to CVB3
(MOI = 100) for 60 min and stained as decsribed in Materials and Methods. Blue =DAPI-stained nuclei, red = externalized virus (VP1external), and
green= internalized virus (VP1internal). (C) Still images captured at the indicated times in HBMEC monolayers treated with control, genistein, or PP2,
loaded with Fura-2AM, and exposed to CVB. (D) Intensity ratio plot (340/380 nm) of control (no inhibitor)-, genistein-, or PP2-treated HBMEC loaded
with Fura-2AM and exposed to CVB3 (t = 55 seconds).
doi:10.1371/journal.ppat.1001135.g005
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Figure 6. Calpain-2 is required for vesicular trafficking of internalized CVB. (A) Top: Representative images of HBMEC and Caco-2
monolayers transfected with control, calpain-1, or calpain-2 siRNAs and infected with CVB (MOI = 1) for 14 hrs (HBMEC) or 7 hrs (Caco-2). VP1 in green
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Growth Supplement (BD Biosciences) and have been described
previously [56]. Primary HAEC were obtained from Lonza-
Clonetics (Allendale, NJ) and cultured in EGM-2 media per
manufacturer’s instructions. Caco-2 (BBE clone) were purchased
from the ATCC and grown in DMEM-H supplemented with 10%
FBS and 10 U/ml PenStrep. CVB3-RD and CVB4 were
expanded by infecting HeLa cells, purified through centrifugation
in a sucrose gradient, and tittered by plaque assays on HeLa cells
as described previously [2].
Antibodies
Mouse anti-enterovirus VP1 (Ncl-Entero) was obtained from
Novocastra Laboratories (New Castle upon Tyne, UK). Goat
polyclonal antibodies to calpain-2 (N-19) was purchased from
Santa Cruz Biotechnology (Santa Cruz, CA). Alexa fluor-
conjugated secondary antibodies and cholera toxin B were
purchased from Invitrogen (Carlsbad, CA).
Inhibitors
Genistein (20 mM), ALLN (50 mM), calpeptin (10 mM), dideox-
yadnesoine (5 mM), PP2 (10 mM), and calpain inhibitor III (5 mM)
were purchased from Calbiochem (Gibbstown, NJ); U73122
(700 mM), Bapta-AM (10 mM), 2-APB (30 mM), and dynasore
(100 mM) were purchased from Sigma (St. Louis, MO). Toxicity
panels were performed to ensure inhibitors did not cause
unwanted effects (Supplemental Figure S7).
Immunofluorescence microscopy
HBMEC monolayers grown in collagen-coated chamber slides
(BD Biosciences, San Jose, CA) were exposed to CVB in binding
buffer for 1 hour at 16uC then washed and placed at 37uC to
initiate entry (for entry experiments), or 14 hours at 37uC (for
infection experiments). For entry experiments the cells were
washed and fixed with 4% paraformaldehyde (PFA) and then
incubated with primary VP1 antibody for 1 hour. Each well was
then washed and incubated with the appropriate Alexa Fluor-594-
conjugated antibody for 30 min. After another washing the cells
were fixed again with 4% PFA, washed, permeabilized with 0.1%
Triton-X 100 in PBS, incubated again with VP1 primary antibody
for 1 hour at room temperature, washed, and subsequently
incubated with Alexa Fluor-488-conjugated secondary antibody
for 30 min, washed, and then mounted with Vectashield (Vector
Laboratories, Burlingame CA). For infection experiments cells
were exposed to virus at MOIs stated then washed and fixed with
ice-cold methanol acetone (3:1). Monolayers were then incubated
with primary VP1 antibody for 1 hour, washed, and incubated
with secondary Alexa Fluor–488-conjugated antibody. Cells were
imaged on an Olympus IX81 inverted microscope equipped with
a motorized stage for obtaining Z stacks. For virus entry
experiments, images were captured with an Olympus PlanApo
60x/1.42 NA oil objective with z stacks (0.25 mM slices) and
deconvolution performed by using the nearest neighbor function
in Slidebook 5.0. Infection images were captured with an Olympus
UplanApo 10x/0.4 NA objective and quantified using ImageJ
(http://rsb.info.nih.gov/ij/) as a ratio of VP1+/DAPI+.
Immunofluorescence-based assay for internalized virus
Immunoflorescence imaging for internalized viral particles was
performed as described in detail previously [18]. Briefly, mono-
layers were exposed to CVB (50 particles/cell) and at the indicated
times fixed in 4% PFA, washed in PBS containing 50 mM NH4Cl
for 5 min, and incubated with monoclonal anti-VP1 antibody
(NCL-ENTERO) for 1 h at RT. Cells were then washed and
incubated with Alexa Fluor (AF) 594-conjugated secondary
antibody. Following washing, cells were fixed again in 4% PFA,
incubated for 5 min in PBS containing 50 mM NH4Cl, and
permeabilized with 0.1% Triton X-100 for 10 min. Permeabilized
monolayers were re-incubated with anti-VP1 antibody, washed,
and incubated with AF 488-conjugated secondary antibody. Cells
were mounted with Vectashield containing DAPI and images
captured as described above.
Ratiometric calcium imaging
Cells grown on collagen-coated glass bottom 35 mm dishes
(MatTek Corp., Ashland, MA) were loaded with Fura-2 AM
(1 mM - Invitrogen) for 30 min at 37uC. These culture conditions
promoted the formation of polarized monolayers characterized by
the asymmetric localization of apical and basolateral protein
components (Supplemental Figure S2B). Cells were rinsed 3 times
with Ca2+- and Mg2+-free PBS, bathed in a final volume of 1 ml.
Images were captured on an Olympus IX81 motorized inverted
microscope equipped with a Hamamatsu Orca-R2 CCD camera,
Sutter Lambda 10-3 High Speed filter wheel system, and an
Olympus UApo/340 20x objective with an N.A. of 0.75. Images
were acquired using Slidebook 5.0 advanced imaging software.
Selected cells were chosen (40 regions of interest (ROI)/dish) and
images captured at both excitation 340 nm and 380 nm every 5
seconds for 10 minutes (experiments were performed a minimum
of three times). Virus was added to dishes once baseline was
established (t = 55 sec) at the specified MOIs. Intensity ratios for
selected ROIs were calculated using Slidebook 5.0, and replicates
averaged and plotted as a function of time. Images were
pseudocolored (using Slidebook 5.0) in order to better visualize
Cai
2+ mobilization with blue = low Cai
2+ and red = high Cai
2+.
siRNA transfections
siRNAs were purchased from Dharmacon. HBMEC were
transfected using HiPerFect (Qiagen, Valencia, CA) as described
and DAPI-stained nuclei in blue. Bottom: Effect of calpain-1 or calpain-2 siRNA transfection on CVB infection of HBMEC (left) or Caco-2 (right) cells.
Shown are the percentage of infected cells (normalized to DAPI-stained nuclei) normalized control siRNA-transfected cells (B) HBMEC monolayers
were treated with the indicated calpain inhibitors and infected with CVB (MOI = 1) for 14 hrs. Inhibitor was added to cultures 1 hr before infection
(pre-treat) or 2 hrs p.i. Dashed line indicates the infection level of control cells. (C) Calpain activity was measured in HBMEC infected with CVB (50
PFU/cell) for the indicated times. Dashed line indicates calpain activity in control (no virus) cells. (D) Immunofluorescence microscopy in HBMEC (top)
and Caco-2 (bottom) exposed to CVB (MOI = 50) for 60 min and treated with DMSO (no inhibitor) or calpain inhibitor III. Green staining represents
internalized virus. White arrows denote enlarged virus-contained vesicles in calpain inhibitor III-treated cells. (E) Immunofluorescence microscopy in
HBMEC exposed to CVB (MOI = 50) for 60 min and treated with either control (No Inh) or with calpain inhibitor III. VP1 (green), calpain-2 (red), and
DAPI (blue). White arrows denote enlarged virus-containing vesicles in calpain inhibitor III-treated cells that colocalize with calpain-2. (F)
Immunofluorescence microscopy in HBMEC exposed to CVB (MOI = 50) and Alexa Fluor-488 conjugated cholera toxin B (CTB) for 60 min and treated
with either control (No Inh) or with calpain inhibitor III. CTB (green), VP1 (red), and DAPI (blue). White arrows denote enlarged CTB and virus-
containing vesicles in calpain inhibitor III-treated cells that colocalize with calpain-2. (G) Immunofluorescence microscopy in HBMEC transfected with
control, PLCc-1, or IP3R-3 siRNAs and stained for internalized CVB (MOI = 50, in green) and DAPI (in blue) at 60 minutes p.i. White arrows denote
enlarge virus-containing vesicles in PLCc-1 and IP3R-3 siRNA treated cells.
doi:10.1371/journal.ppat.1001135.g006
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previously [3]. Reverse transfections were performed as follows–
OptiMEM:HiPerfect complexes were incubated for 10 min with
the indicated siRNAs and then added to cells in suspension
(harvested following trypsinization) and incubated for 48–72
hours. In some cases, siRNAs were delivered by nucleofection
[Nucleofector System (Amaxa) using Nucleofector solution V and
program T023].
RT-PCR
Total RNA was isolated with TRI Reagent Solution (Applied
Biosystems, Foster City, CA) according to the manufacturer’s
protocol. For complementary DNA synthesis, 1 mg total RNA was
used in a 20-mL reaction containing 1 mM deoxynucleotide
triphosphates (dNTPs), 2.5 mM oligo dT or random hexamers (for
CVB amplification), 1000 U/ml RNase inhibitor, 0.1 volume 10X
buffer (supplied by manufacturer), and 2500 U/ml murine
leukemia virus reverse transcriptase (Invitrogen, Carlsbad, CA).
The reverse transcription (RT) reaction was carried out at 1 cycle
in a thermal cycler at 42uC for 50 min, followed by 15 min
incubation at 70uC. PCR for IP3R-2 was carried out with primers
to the gene of interest (primer sequences can be found in
Supplemental Figure S5B) and Taq DNA polymerase for 25 cycles.
PCR products were separated on a 1% agarose gel containing
ethidium bromide. Primer sequences are as follows: IP3R-2 (sense
59-CTTGAAGATCTGGGGGATCA-39 and antisense 59-GTG-
CCTTCTTTTGCCTCTTG-39); IP3R-1 (sense 59-CAAGC-
GAGTTCCTGTTCTCC-39 and antisense 59-GTGGACTCC-
AGCTTCTCCTG-39); GAPDH (sense 59-ACCACCAACT-
GCTTAGCA-39 and antisense 59-CCCTGTTGCTGTAGC-
CAA-39). CVB PCR was performed using a Maxim Biotech
amplification kit for enteroviruses as per the manufacturer’s
instructions.
Calpain activation assay
Calpain activity was assessed in HBMEC exposed to CVB (100
PFU/cell) at the indicated times using a fluorogenic calpain
activity assay (Calbiochem). Briefly, control or CVB-exposed cells
(at the indicated times) were lysed in RIPA buffer (without
protease inhibitors) and incubated with fluorogenic calpain
substrate for 15 min at room temperature. Fluorescence intensity
measurements were acquired using a fluorescence plate reader
(BioTek Synergy 4, BioTek) at an excitation wavelength of ,360–
380 nm and an emission wavelength of ,440–460 nm. Readings
were normalized to background (RIPA alone) controls and data
presented as the fold change in calpain activity in CVB-exposed
cells compared to no virus controls.
Accession numbers
ID numbers for proteins/genes mentioned in the text (numbers
were taken from GenBank at Pubmed): inositol 1,4,5-trispho-
sphate receptor 1 (ITPR1) 3708; inositol 1,4,5-trisphosphate
receptor 3 (ITPR3) 3710; phospholipase C gamma-1 (PLCG1)
5335; decay accelerating factor (DAF or CD55) 1604; coxsack-
ievirus and adenovirus receptor (CXADR) 1525; calpain-2
(CAPN2) 824; calpain-1 (CAPN1) 823; Tec kinase (TEC) 7006;
dynamin (DNM1) 1759; dynamin II (DNM2) 1785; caveolin-1
(CAV1) 857; caveolin-3 (CAV3) 859; EPS15 2060.
Supporting Information
Figure S1 CVB-induced Cai
2+ depletion occurs prior to uncoat-
ing and replication. (A) HBMEC were treated with Bapta-AM and
infected with VSV (MOI=1) for 8 hrs. Inhibitor was added to
cultures 1 hr before (pre-treat) or 2 hrs after (post-treat). The graph
indicates the percentage of cells expressing VSV-G compared to
control (dashed line). (B) RT-PCR or (C) Western blot analysis of
RNA/protein collected from HBMEC infected with CVB (10
PFU/cell) for the indicated times. Negative [(-) no infection] and
positive [(+) overnight infection with CVB] are shown. (D) 35S-
labeled virus particle at various stages of internalization were
recovered by cell lysis with sucrose gradient lysis buffer (10mMTris-
HCl, pH 7.6, 1mM NaCl, 1mM EDTA, 1% NP40, 0.5% sodium
dodecyl sulfate (SDS). Cell lysates were overlaid on linear 15-30%
sucrose gradients and centrifuged at 39,000 rpm for 150 min at 4uC
in a Beckman SW41Ti rotor. Fractions (400 ml) were collected from
the top of the gradient and radioactivity was measured.
Found at: doi:10.1371/journal.ppat.1001135.s001 (0.32 MB
TIF)
Figure S2 CAR is sequestered in the tight junctions of HBMEC.
(A) HBMEC were transfected with control, CAR, or DAF siRNAs
and exposed to S35-labeled CVB (12,000 cpms) at 16uC for one
hour. Following binding, cells were washed, lysed, and radio-
activity was counted. (B) Confocal micrographs of HBMEC
immunostained for the basolateral-localized Na+/K+ ATPase
pump (green) and the tight junction marker ZO-1 (red) (DAPI -
blue). (C) Confocal micrographs of CAR (green) and ZO-1 (red,
left), or E-cadherin (red, right).
Found at: doi:10.1371/journal.ppat.1001135.s002 (1.97 MB
TIF)
Figure S3 IP3R-1 and -2 siRNAs have modest effects on CVB-
induced Cai
2+ mobilization. (A) Intensity ratio graph of HBMEC
transfected with control, IP3R-1, or IP3R-2 siRNAs, loaded with
Fura-2AM and exposed to CVB (55 sec). (B) Still images of Fura-
2-loaded HBMEC transfected with control, IP3R-1, or IP3R-2
siRNAs and exposed to CVB.
Found at: doi:10.1371/journal.ppat.1001135.s003 (3.27 MB
TIF)
Figure S4 Tyrosine kinases are required for CVB-induced Cai
2+
release in HAEC. (A) Intensity ratio graph of HAEC pre-treated
with control (no inhibitor) or genistein and exposed to CVB (55
sec). (B) Still images of Fura-2 loaded HAEC with or without
genistein and exposed to CVB.
Found at: doi:10.1371/journal.ppat.1001135.s004 (1.54 MB
TIF)
Figure S5 Efficacy of siRNA silencing in HBMEC. Western blot
or RT-PCR analysis in HBMEC transfected with the indicated
siRNAs: control (CON), calpain-1 (CALP1), calpain-2 (CALP2),
CAR, DAF, dynamin II (DNMII), IP3R1, IP3R2, IP3R3, or
PLCc1 (PLCG1). For immunoblots, membranes were stripped
and reprobed with GAPDH as a loading control. For RT-PCR,
cDNA was amplified using GAPDH primers.
Found at: doi:10.1371/journal.ppat.1001135.s005 (0.39 MB
TIF)
Figure S6 Calpain-2 is required for viral trafficking in HAEC
and HBMEC. (A) Caco-2 monolayers were treated with the
indicated calpain inhibitors and infected with CVB (MOI=1) for
7hrs (Caco-2). Inhibitor was added to cultures 1 hr before infection
(pre-treat) or 2 hrs p.i. Dashed line indicates the infection level of
control cells. (B) Primary HAEC cells were treated with calpain
inhibitor III and infected with CVB. Inhibitor was added to
cultures 1 hr before infection (pre-treat) or 2 hrs p.i. (C)
Quantification of vesicles (with diameter .500nM) in HBMEC
in the absence or presence of calpain inhibitors. Data are
presented as the percent of total cells containing vesicles
.500nM in diameter (total number of cells counted - 75 for no
inhibitor and 117 for calpain inhibitors). (D) Representative
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images of the quantification shown in (C). VP1 (green) and DAPI
(blue). (E) Quantification of vesicles (with diameter .500nM) in
HBMEC transfected with control siRNA, PLCG1 siRNA, and
IP3R-3 siRNA. (F) Confocal images of HBMEC stained for
calpain 2 (red) and stained with mouse monoclonal Rab5 GTPase
(green) (2143, Cell Signaling Technology).
Found at: doi:10.1371/journal.ppat.1001135.s006 (1.63 MB
TIF)
Figure S7 Toxicity panels for pharmacological inhibitors and
siRNAs. (A) Extent of PI uptake in HBMEC following 7 hr
incubation with the indicated inhibitors. Toxicity was calculated as
the percent of cells positive for PI/total cells. (B) Induction of type
I interferon signaling in HBMEC transfected with a luciferase
reporter plasmid and then select siRNAs. Data are presented as a
fold increase in comparison to control (no siRNA) levels.
Found at: doi:10.1371/journal.ppat.1001135.s007 (0.93 MB
TIF)
Movie S1 Intracellular calcium store depletion is observed
immediately after exposure of HBMEC monolayers to CVB3.
Time-lapse movie of HBMEC loaded with Fura-2AM and exposed
to CVB3 (50 PFU/ml) in real time. Movie is pseudocolored for
better visualization of calcium (blue= low, red=high).
Found at: doi:10.1371/journal.ppat.1001135.s008 (6.36 MB
MOV)
Movie S2 Intracellular calcium store depletion is also observed
immediately after exposure of HAEC to CVB3. Time-lapse movie
of HAEC monolayers loaded with Fura-2AM and exposed to
CVB (50 PFU/cell) in real time. Movie is pseudocolored for better
visualization of calcium (blue = low, red =high).
Found at: doi:10.1371/journal.ppat.1001135.s009 (8.60 MB
MOV)
Movie S3 Epithelial Caco-2 monolayers exposed to CVB3 do
not mobilize intracellular calcium. Time-lapse movie of Caco-2
monolayers loaded with Fura-2AM and exposed to CVB (50
PFU/cell) in real time. Movie was pseudocolored for better
visualization of calcium (blue = low, red =high).
Found at: doi:10.1371/journal.ppat.1001135.s010 (10.37 MB
MOV)
Movie S4 CVB4 does not induce intracellular calcium release of
HBMEC monolayers. Time-lapse movie of HBMEC monolayers
loaded with Fura-2AM and exposed to CVB4 (50 PFU/cell) in
real time. Movie was pseudocolored for better visualization of
calcium (blue = low, red= high).
Found at: doi:10.1371/journal.ppat.1001135.s011 (9.93 MB
MOV)
Movie S5 Intracellular calcium store depletion in response to
CVB3 is not dependent on CAR. Time-lapse movie of HBMEC
monolayers transfected with CAR siRNA, loaded with Fura-2AM,
and exposed to CVB3 (50 PFU/ml) after 1 min. Movie is
pseudocolored for better visualization of calcium (blue = low,
red =high).
Found at: doi:10.1371/journal.ppat.1001135.s012 (6.78 MB
MOV)
Movie S6 PLCG1 is required for calcium store depletion in
response to CVB3. Time-lapse movie of HBMEC monolayers
transfected with PLCG1 siRNA, loaded with Fura-2AM, and then
exposed to CVB3 (50 PFU/ml) after 1 min. Movie was
pseudocolored for better calcium visualization (blue = low, red= -
high).
Found at: doi:10.1371/journal.ppat.1001135.s013 (10.32 MB
MOV)
Movie S7 IP3R1 siRNA has a modest effect on calcium
mobilization in response to CVB3. Time-lapse movie of HBMEC
monolayers transfected with IP3R-1 siRNA, loaded with Fura-
2AM, and exposed to CVB3 (MOI=50) after 1 min. Movie was
pseudocolored for better calcium visualization (blue = low, red= -
high).
Found at: doi:10.1371/journal.ppat.1001135.s014 (10.19 MB
MOV)
Movie S8 IP3R-2 siRNA has a modest affect on calcium store
depletion in response to CVB3. Time-lapse movie of HBMEC
monolayers transfected with IP3R-2 siRNA, loaded with Fura-
2AM, and exposed to CVB3 (MOI= 50) after 1 min. Movie is
pseudocolored for better calcium visualization (blue = low, red= -
high).
Found at: doi:10.1371/journal.ppat.1001135.s015 (10.89 MB
MOV)
Movie S9 IP3R-3 siRNA reveals its involvement in calcium store
depletion upon exposure to CVB3. HBMEC monolayers were
transfected with IP3R-3 siRNA, loaded with Fura-2AM, and
exposed to CVB3 (MOI= 50) after 1 min. Movie was pseudoco-
lored for better calcium visualization (blue = low, red= high).
Found at: doi:10.1371/journal.ppat.1001135.s016 (10.48 MB
MOV)
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